These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9725088)

  • 1. HLA-B27 and other predisposing factors in spondyloarthropathies.
    Khare SD; Luthra HS; David CS
    Curr Opin Rheumatol; 1998 Jul; 10(4):282-91. PubMed ID: 9725088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-B27 subtypes: implications for the spondyloarthropathies.
    MacLean L
    Ann Rheum Dis; 1992 Aug; 51(8):929-31. PubMed ID: 1417115
    [No Abstract]   [Full Text] [Related]  

  • 3. Spontaneous inflammatory disease in HLA-B27 transgenic mice does not require transporter of antigenic peptides.
    Khare SD; Lee S; Bull MJ; Hanson J; Luthra HS; David CS
    Clin Immunol; 2001 Mar; 98(3):364-9. PubMed ID: 11237560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunology, genetics, and animal models of the spondyloarthropathies.
    Taurog JD
    Curr Opin Rheumatol; 1990 Aug; 2(4):586-91. PubMed ID: 2206800
    [No Abstract]   [Full Text] [Related]  

  • 5. Genetics of the spondyloarthropathies.
    Woodrow JC
    Curr Opin Rheumatol; 1991 Aug; 3(4):586-91. PubMed ID: 1911054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spondyloarthropathies.
    Khan MA
    Curr Opin Rheumatol; 1998 Jul; 10(4):279-81. PubMed ID: 9725087
    [No Abstract]   [Full Text] [Related]  

  • 7. Unraveling the mystery of HLA-B27 association with human spondyloarthropathies using transgenic and knock out mice.
    Khare SD; Luthra HS; David CS
    Semin Immunol; 1998 Feb; 10(1):15-23. PubMed ID: 9529652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetics and immunology of the spondyloarthropathies.
    Taurog JD
    Curr Opin Rheumatol; 1989 Aug; 1(2):144-50. PubMed ID: 2701553
    [No Abstract]   [Full Text] [Related]  

  • 9. Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta 2m: an animal model of HLA-B27-associated human disorders.
    Hammer RE; Maika SD; Richardson JA; Tang JP; Taurog JD
    Cell; 1990 Nov; 63(5):1099-112. PubMed ID: 2257626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Animal models of human leukocyte antigen B27-linked arthritides.
    Khare SD; Luthra HS; David CS
    Rheum Dis Clin North Am; 1998 Nov; 24(4):883-94, xi-xii. PubMed ID: 9891716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predisposing factors to spondyloarthropathies.
    Brown M; Wordsworth P
    Curr Opin Rheumatol; 1997 Jul; 9(4):308-14. PubMed ID: 9229177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MICA allele typing of HLA-B27 positive Japanese patients with seronegative spondylarthropathies and healthy individuals: differential linkage disequilibrium with HLA-B27 subtypes.
    Tsuchiya N; Shiota M; Moriyama S; Ogawa A; Komatsu-Wakui M; Mitsui H; Geraghty DE; Tokunaga K
    Arthritis Rheum; 1998 Jan; 41(1):68-73. PubMed ID: 9433871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of enterobacteria and HLA-B27 in spondyloarthropathies: studies with transgenic mice.
    Nickerson CL; Luthra HS; David CS
    Ann Rheum Dis; 1990 Jun; 49 Suppl 1():426-33. PubMed ID: 2115764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arthritis in HLA-B27 transgenic animals.
    Taurog JD
    Am J Med Sci; 1998 Oct; 316(4):250-6. PubMed ID: 9766486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spontaneous inflammatory arthritis in HLA-B27 transgenic mice lacking beta 2-microglobulin: a model of human spondyloarthropathies.
    Khare SD; Luthra HS; David CS
    J Exp Med; 1995 Oct; 182(4):1153-8. PubMed ID: 7561688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA-B27 transgenic mice are susceptible to collagen-induced arthritis: type II collagen as a potential target in human disease.
    Lee S; Khare SD; Griffiths MM; Luthra HS; David CS
    Hum Immunol; 2000 Feb; 61(2):140-7. PubMed ID: 10717806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of HLA-B27 in spondyloarthritis.
    Allen RL; Bowness P; McMichael A
    Immunogenetics; 1999 Nov; 50(3-4):220-7. PubMed ID: 10602882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pathogenetic aspects of spondyloarthropathies from the point of view of HLA-B27.
    Kellner H; Yu D
    Rheumatol Int; 1992; 12(4):121-7. PubMed ID: 1439478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-B27 heavy chains contribute to spontaneous inflammatory disease in B27/human beta2-microglobulin (beta2m) double transgenic mice with disrupted mouse beta2m.
    Khare SD; Hansen J; Luthra HS; David CS
    J Clin Invest; 1996 Dec; 98(12):2746-55. PubMed ID: 8981920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seronegative spondyloarthritides.
    Calin A
    Med Clin North Am; 1986 Mar; 70(2):323-36. PubMed ID: 3485229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.